Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for C1D6V9

Entry ID Method Resolution Chain Position Source
AF-C1D6V9-F1 Predicted AlphaFoldDB

No variants for C1D6V9

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for C1D6V9

No associated diseases with C1D6V9

4 regional properties for C1D6V9

Type Name Position InterPro Accession
domain AMP-dependent synthetase/ligase domain 89 - 528 IPR000873
conserved_site AMP-binding, conserved site 265 - 276 IPR020845
domain AMP-binding enzyme, C-terminal domain 537 - 618 IPR025110
domain Acetyl-coenzyme A synthetase, N-terminal domain 32 - 87 IPR032387

Functions

Description
EC Number 6.2.1.1 Acid--thiol ligases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

4 GO annotations of molecular function

Name Definition
acetate-CoA ligase activity Catalysis of the reaction: ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA.
AMP binding Binding to AMP, adenosine monophosphate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
metal ion binding Binding to a metal ion.

1 GO annotations of biological process

Name Definition
acetyl-CoA biosynthetic process from acetate The chemical reactions and pathways resulting in the formation of acetyl-CoA from acetate, either directly or via acetylphosphate.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSTIESVLKE TRSFPPSEAF RQQATVSGMQ AYNDLCEKAN ADYEGFWADL ARELLSWKKP
70 80 90 100 110 120
FTQVFDGSQA PFFKWFADGQ LNVSYNCLDR HLEHNANKTA IIYETDDGQV TPISYRSLYE
130 140 150 160 170 180
QVCQFANGLK SLGVGKGDRV VIYMPMVPQA IVAMQACARI GAIHSVVFGG FSAGALRDRI
190 200 210 220 230 240
QDAAAKVVIT ANESVRGGKL VPLKATVDEA LAMDGCDSIE KVVVLQRTYT PCSMGARDIT
250 260 270 280 290 300
WDALTAGQPL ECEPEWMSAE DPLFILYTSG STGKPKGIQH SSAGYLLGAA NSFRWAFDYK
310 320 330 340 350 360
PNDIYWCTAD VGWITGHSYI CYGPLAMGAT QVVFEGIPTY PDAGRFWRMI EQHKVNIFYT
370 380 390 400 410 420
APTAIRSLIK LGADLPKQFD LSSLRVLGTV GEPINPEAWM WYYEVVGGGR CPIVDTWWQT
430 440 450 460 470 480
ETGSAMIAPM PGAVATKPGS CTLPLPGIMA DIVDESGAQV EPGRGGFLVI KKPFPSLVRT
490 500 510 520 530 540
IWNDPDRFKK TYFPEEFNGQ YYLAGDSANR DESGYFWIMG RIDDVLNVSG HRLGTMEIES
550 560 570 580 590 600
ALVANPLVAE AAVVGKPHDV KGEAVVAFVV LKGIRPEGDE AKKVAAELKS WVAHEIGKIA
610 620 630 640 650
QPDDIRFGEN LPKTRSGKIM RRLLRSIAKG EEITQDTSTL ENPQILDQLQ EIA